Nektar Therapeutics - 15 Year Stock Price History | NKTR

Historical daily share price chart and data for Nektar Therapeutics since 2011 adjusted for splits and dividends. The latest closing stock price for Nektar Therapeutics as of September 17, 2026 is 68.36.
  • The all-time high Nektar Therapeutics stock closing price was 1626.60 on March 08, 2018.
  • The Nektar Therapeutics 52-week high stock price is 109.00, which is 59.4% above the current share price.
  • The Nektar Therapeutics 52-week low stock price is 33.40, which is 51.1% below the current share price.
  • The average Nektar Therapeutics stock price for the last 52 weeks is 64.00.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Nektar Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2026 67.1582 43.4200 100.3500 35.1200 68.3600 61.68%
2025 28.7203 14.4150 65.6900 7.3560 42.2800 203.08%
2024 17.1215 8.9220 27.4500 7.4040 13.9500 64.60%
2023 14.4814 32.8500 47.2500 6.3405 8.4750 -75.00%
2022 79.4594 204.9000 205.8000 30.4500 33.9000 -83.27%
2021 260.6905 264.9000 381.9000 162.4500 202.6500 -20.53%
2020 298.4283 314.4000 419.4000 217.0500 255.0000 -21.24%
2019 435.5890 513.3000 695.2500 238.0500 323.7750 -34.33%
2018 972.8594 864.7500 1626.6000 456.4500 493.0500 -44.96%
2017 355.0330 190.3500 907.5000 176.2500 895.8000 386.72%
2016 219.4839 243.0000 295.2000 165.0000 184.0500 -27.18%
2015 189.9217 227.4750 261.1500 142.5000 252.7500 8.71%
2014 195.0905 178.0500 255.7500 157.9500 232.5000 36.56%
2013 160.0021 113.1000 209.4000 113.1000 170.2500 53.17%
2012 117.1627 86.4000 162.4500 85.2000 111.1500 32.44%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.301B $0.055B
Nektar Therapeutics is a biopharmaceutical company, focused on the development of treatments utilizing its PEGylation and advanced polymer conjugate technology platforms. Nektar primarily finances its operations with funds from licensing, collaboration and manufacturing agreements. It has collaboration deals with companies namely AstraZeneca, Pfizer, Roche, Amgen, Bristol-Myers and Eli Lilly among others. The company's most lucrative deal is with Bristol-Myers, which provided the company with significant cash resources to support progress of its pipeline and share development costs for its lead candidate, bempegaldesleukin. Nektar recognizes product sales from its manufacturing and supply agreements with several pharma companies related to products developed using its PEGylation platform. The company also earns royalty payments from the sales of products using its technology platforms. Amgen's neutropenia drug, Neulasta is one of the drugs developed using Nektar's PEGylation platform.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $67.606B 22.33
Takeda Pharmaceutical (TAK) Japan $59.727B 11.10
UCB SA (UCBJY) Belgium $44.643B 0.00
BeOne Medicines - (ONC) Switzerland $38.215B 61.28
Otsuka Holdings, - (OTSKY) Japan $37.468B 14.01
Sandoz Group AG (SDZNY) Switzerland $35.090B 0.00
Daiichi Sankyo, - (DSNKY) Japan $33.774B 21.08
Zoetis (ZTS) United States $30.165B 11.09
Astellas Pharma (ALPMY) Japan $26.725B 8.84
United Therapeutics (UTHR) United States $21.380B 17.83
Merck (MKKGY) Germany $19.470B 15.53
Shionogi (SGIOY) Japan $15.760B 9.26
IPSEN (IPSEY) France $15.498B 0.00
Neurocrine Biosciences (NBIX) United States $15.197B 20.65
Summit Therapeutics (SMMT) United States $13.801B 0.00
Orion OYJ (ORINY) Finland $12.984B 18.93
Madrigal Pharmaceuticals (MDGL) United States $12.224B 0.00
Corcept Therapeutics (CORT) United States $12.086B 266.21
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.965B 15.26
Eisai (ESAIY) $9.088B 0.00
Crinetics Pharmaceuticals (CRNX) United States $9.013B 0.00
Ionis Pharmaceuticals (IONS) United States $7.452B 0.00
Ono Pharmaceutical (OPHLF) Japan $7.049B 13.27
Stevanato Group S.p.A (STVN) Italy $6.823B 34.14
Centessa Pharmaceuticals (CNTA) United Kingdom $6.267B 0.00
Oruka Therapeutics (ORKA) United States $6.194B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $5.774B 21.02
Definium Therapeutics (DFTX) United States $5.086B 0.00
Grifols, S.A (GRFS) Spain $5.036B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.923B 0.00
Relay Therapeutics (RLAY) United States $4.129B 0.00
Indivior Pharmaceuticals (INDV) United States $4.054B 9.41
Catalyst Pharmaceuticals (CPRX) United States $3.855B 11.93
Amylyx Pharmaceuticals (AMLX) United States $3.636B 0.00
Enliven Therapeutics (ELVN) United States $3.599B 0.00
Dyne Therapeutics (DYN) United States $3.232B 0.00
Hypermarcas (HYPMY) Brazil $3.196B 9.08
Soleno Therapeutics (SLNO) United States $2.717B 228.83
NewAmsterdam Pharma (NAMS) Netherlands $2.532B 0.00
Guardian Pharmacy Services (GRDN) United States $2.317B 43.89
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.257B 16.63
Ocular Therapeutix (OCUL) United States $2.168B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.154B 5.81
Avadel Pharmaceuticals (AVDL) Ireland $2.113B 0.00
Xencor (XNCR) United States $1.763B 0.00
KARDIGAN INC (KARD) United States $1.619B 0.00
Xeris Biopharma Holdings (XERS) United States $1.418B 111.14
Harrow (HROW) United States $1.282B 0.00
Aktis Oncology (AKTS) United States $1.221B 0.00
Cronos Group (CRON) Canada $1.213B 29.91
Seaport Therapeutics (SPTX) United States $1.185B 0.00
Bioventus (BVS) United States $1.110B 17.37
Savara (SVRA) United States $1.054B 0.00
Cybin (HELP) Canada $1.018B 0.00
KalVista Pharmaceuticals (KALV) United States $0.993B 0.00
Avalo Therapeutics (AVTX) United States $0.889B 0.00
Theravance Biopharma (TBPH) United States $0.884B 0.00
Ardelyx (ARDX) United States $0.845B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.823B 11.35
Esperion Therapeutics (ESPR) United States $0.819B 0.00
Achieve Life Sciences (ACHV) Canada $0.764B 0.00
4D Molecular Therapeutics (FDMT) United States $0.760B 0.00
Apnimed (APMD) $0.754B 0.00
Silence Therapeutics (SLN) United Kingdom $0.753B 0.00
Aclaris Therapeutics (ACRS) United States $0.744B 0.00
Collegium Pharmaceutical (COLL) United States $0.722B 3.18
Zevra Therapeutics (ZVRA) United States $0.701B 7.47
Ironwood Pharmaceuticals (IRWD) United States $0.689B 5.35
Altimmune (ALT) United States $0.630B 0.00
OmniAb (OABI) United States $0.630B 0.00
Aquestive Therapeutics (AQST) United States $0.605B 0.00
Evotec AG (EVO) Germany $0.580B 0.00
ProKidney (PROK) United States $0.559B 0.00
Relmada Therapeutics (RLMD) United States $0.450B 0.00
Indaptus Therapeutics (INDP) United States $0.428B 0.00
ARS Pharmaceuticals (SPRY) United States $0.414B 0.00
Larimar Therapeutics (LRMR) United States $0.408B 0.00
Prelude Therapeutics (PRLD) United States $0.357B 0.00
Lexeo Therapeutics (LXEO) United States $0.341B 0.00
Century Therapeutics (IPSC) United States $0.337B 0.00
Inhibikase Therapeutics (IKT) United States $0.322B 0.00
Avita Medical (RCEL) United States $0.322B 0.00
Pyxis Oncology (PYXS) United States $0.279B 0.00
USANA Health Sciences (USNA) United States $0.272B 14.86
Lyell Immunopharma (LYEL) United States $0.264B 0.00
Elite Pharmaceuticals (ELTP) United States $0.264B 12.25
Akebia Therapeutics (AKBA) United States $0.254B 0.00
Galectin Therapeutics (GALT) United States $0.242B 0.00
Nature's Sunshine Products (NATR) United States $0.230B 11.19
Siga Technologies (SIGA) United States $0.223B 0.00
Cardiol Therapeutics (CRDL) Canada $0.221B 0.00
Protara Therapeutics (TARA) United States $0.214B 0.00
Profound Medical (PROF) Canada $0.213B 0.00
AleAnna (ANNA) United States $0.210B 16.58
Journey Medical (DERM) United States $0.206B 0.00
Korro Bio (KRRO) United States $0.204B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.202B 0.00
Surrozen (SRZN) United States $0.197B 0.00
Organogenesis (ORGO) United States $0.179B 0.00
MediWound (MDWD) Israel $0.170B 0.00
Minerva Neurosciences (NERV) United States $0.166B 0.00
Atrium Therapeutics (RNA) United States $0.163B 0.00
NRx Pharmaceuticals (NRXP) United States $0.145B 0.00
Innate Pharma SA (IPHYF) France $0.138B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.136B 0.00
Unicycive Therapeutics (UNCY) United States $0.133B 0.00
Assertio Holdings (ASRT) United States $0.116B 0.00
VAXART, INC (VXRT) United States $0.115B 2.96
Vivani Medical (VANI) United States $0.110B 0.00
Rafael Holdings (RFL) United States $0.107B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.105B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.103B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
PolyPid (PYPD) Israel $0.099B 0.00
ElectroCore (ECOR) United States $0.096B 0.00
HST Global (HSTC) United States $0.092B 0.00
Fractyl Health (GUTS) United States $0.090B 0.00
Nutriband (NTRB) United States $0.086B 0.00
Aldeyra Therapeutics (ALDX) United States $0.083B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.078B 0.00
Telomir Pharmaceuticals (TELO) United States $0.078B 0.00
PMV Pharmaceuticals (PMVP) United States $0.076B 0.00
Gain Therapeutics (GANX) United States $0.075B 0.00
Acrivon Therapeutics (ACRV) United States $0.073B 0.00
Champions Oncology (CSBR) United States $0.069B 0.00
Talphera (TLPH) United States $0.062B 0.00
Nuo Therapeutics (AURX) $0.061B 0.00
Heron Therapeutics (HRTX) United States $0.060B 0.00
Dominari Holdings (DOMH) United States $0.052B 0.00
Veraxa Biotech AG (VRXA) United States $0.048B 0.00
Incannex Healthcare (IXHL) Australia $0.045B 0.00
SCYNEXIS (SCYX) United States $0.041B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Karyopharm Therapeutics (KPTI) United States $0.039B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Context Therapeutics (CNTX) United States $0.035B 0.00
Lite Strategy (LITS) United States $0.035B 0.00
TransCode Therapeutics (RNAZ) United States $0.028B 0.00
Optimi Health (OPTH) Canada $0.028B 0.00
Cosmos Health (COSM) United States $0.028B 0.00
Plus Therapeutics (PSTV) United States $0.027B 0.00
TherapeuticsMD (TXMD) United States $0.025B 0.00
Universe Pharmaceuticals INC (UPC) China $0.024B 0.00
Tempest Therapeutics (TPST) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Klotho Neurosciences (KLTO) United States $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.015B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.015B 0.00
BioVie (BIVI) United States $0.015B 0.00
Enlivex (ENLV) Israel $0.014B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.014B 0.00
Vyome Holdings (HIND) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Natural Alternatives (NAII) United States $0.012B 0.00
BioLineRx (BLRX) Israel $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
CASI Pharmaceuticals (CASI) China $0.010B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Wellgistics Health (WGRX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Inotiv (NOTV) United States $0.008B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.007B 0.00
Ernexa Therapeutics (ERNA) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.005B 0.00
Liminatus Pharma (LIMN) United States $0.004B 0.00
Nuvilex (PMCB) United States $0.004B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Addex Therapeutics (ADXN) Switzerland $0.004B 0.00
Niki BioSolutions (NIKI) United Kingdom $0.004B 0.00
Galmed Pharmaceuticals (EOCN) Israel $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Jupiter Neurosciences (JUNS) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Vivos Therapeutics (VVOS) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
Clearmind Medicine (CMND) Canada $0.001B 0.00
CDT Equity (CDT) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00